HomeYMAB • NASDAQ
add
Y-mAbs Therapeutics Inc
Previous close
$3.86
Day range
$3.82 - $4.12
Year range
$3.55 - $16.10
Market cap
185.66M USD
Avg Volume
252.80K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 20.90M | 4.88% |
Operating expense | 23.52M | -4.74% |
Net income | -5.20M | 21.62% |
Net profit margin | -24.86 | 25.26% |
Earnings per share | -0.12 | 20.00% |
EBITDA | -5.55M | 17.80% |
Effective tax rate | -0.10% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 60.31M | -20.38% |
Total assets | 112.61M | -8.68% |
Total liabilities | 23.16M | -4.02% |
Total equity | 89.46M | — |
Shares outstanding | 45.28M | — |
Price to book | 1.95 | — |
Return on assets | -12.08% | — |
Return on capital | -15.36% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -5.20M | 21.62% |
Cash from operations | -6.91M | -98.76% |
Cash from investing | -127.00K | — |
Cash from financing | 114.00K | -80.61% |
Net change in cash | -6.92M | -139.75% |
Free cash flow | -3.66M | -27.58% |
About
Founded
2015
Website
Employees
104
